Clarkston Consulting

A successful #MES solution integration demands a strategic approach. Here are a few change management best practices for a MES implementation. https://hubs.ly/Q03cxB3T0

Explore our 2025 annual BioFlorida, Inc. Showcase key takeaways, from the March 19th showcase that was themed “Thriving and Emerging in Florida." Read here: https://hubs.ly/Q03cY71q0 1. Miami International Airport Focuses on Pharma and Medical Equipment  2. Workforce Challenges in South Florida for Biotech Companies  3. Building Awareness to the Local Communities And Universities    4. Capital Funding Remains a Large Issue 5. Navigating Drug Development and Commercialization Challenges  6. Regulatory Hurdles in South Florida’s BioTech Sector  7. Tapping into Spanish-Speaking and Latin American Markets 8. Supply Chain Challenges in South Florida’s BioTech Sector 9. AI for Drug Formulation and Testing Takeaways by Clarkston Consulting's Sebastian Valencia, Laurie Stone, and Arturo Blasi

Clarkston Consulting recently executed a product repositioning for a pharmaceutical company. Read the case study: https://hubs.ly/Q03cpNdF0 #Pharma #ProductRepositioning #LifeSciencesMarketing

How you should approach your #MES vendor selection and implementation to maximize your investment decision? Here are five considerations. https://hubs.ly/Q03cxMBw0 #implementation #VendorSelection #QualityManagement

What are the impacts of the #BIOSECURE Act on #CDMO (Contract Development and Manufacturing Organization) selections? In this post, we're sharing key considerations in the areas of strategic sourcing, R&D, and executive leadership. https://hubs.ly/Q03cxGW30 #StrategicSourcing #ResearchDevelopment #ExecutiveLeadership

Is your organization able to communicate the "Why" of a project? A goal-driven #VisionStatement can motivate a diverse team to work towards achieving a successful transformation, but it is the discussion around how to create a vision statement that really drives #alignment. Here's how: https://hubs.ly/Q03cpT2p0

This week at DCAT (Drug, Chemical & Associated Technologies Association) 2025, we’ve heard valuable insights on the topic of the global bio and pharmaceutical manufacturing value chain. Here are some themes we’ve heard: 1. Demand is exceeding #supply  2. Global demand for #bioreactors is growing  3. CROs, CDOs and CMOs are making heavy investments to increase #capacity across the world (US, China, India, Switzerland, etc.) 4. Forecasted top areas of #spending are: oncology, immunology, diabetes, cardiovascular, CNS, respiratory, and obesity 5. Innovation is growing in the #CNS space (particularly seeing large growth in the areas of Alzheimer’s Disease, Anxiety/Depression, Schizophrenia/Bipolar, and Pain) Takeaways by Anand Nataraj

In October, the FDA took a significant step forward by releasing a new Q&A guidance clarifying the use of electronic systems, e-records, and e-signatures in clinical investigations. Clarkston Consulting's Randall Jacobs and Laurie Stone share a helpful summary here: https://hubs.ly/Q03cxMtH0 #ClinicalTrials #Regulatory

Today at SAPinsider Las Vegas, Crescense's Dave Treadaway attended "Netflix's Customer Obsession," a keynote delivered by Gibson Biddle. As the former VP of Product at Netflix, Biddle discussed the importance of putting the customer at the center of everything. Netflix prioritized the concept of "Customer Obsession" and took the following approach to really understand and delight their customers: * Identified qualitative data through focus groups, 1-1, and usability, * Compiled survey data to identify key metrics like NPS, * Analyzed existing data for the customer and the business, * Completed AB testing to measure change, and * Maintained a focused strategy throughout the process. Really interesting perspective for those in the #retail and #consumerproducts industries to keep in mind! #SAPInsiderLasVegas #SAPiVegas25 #SAPCommunity

Clarkston Consulting’s Lynette Nazabal attended Pharma MES this week alongside MES and manufacturing IT experts in the #pharma and #biotech industry who discussed how to optimize a MES strategy! A key insight from the conference was … The need for a flexible and modern #MES has never been more critical for life science #manufacturers to support increasing complexities of bio modalities and to enable growth for diverse pipelines. Companies are leveraging next-gen MES in global facility expansion. Learn more about the power of #ManufacturingExecutionSystems here: https://hubs.ly/Q03cyBBJ0